Robust Biosimilars Development Efforts Drives Opportunities for Tools Needed for Handling, Processing & Characterizing Biomolecules
Robustly
growing Biosimilars market supported by the strong focus on reducing drug
prices and cost of healthcare is poised to drive the global
market for Commercial Biotechnology Separation Systems to exceed US$31.7
billion by 2024.
Biological
products are of significant importance in a wide range of sectors including
food, cosmetic and pharmaceutical industries. Separating biomolecules and
proteins such as RNA and DNA are key processes in commercial production of
biotechnology products. These macromolecules are separated from their source
material for their use in analysis as well as in production of biotechnological
products. While in some applications biological products need little further
processing and can be employed as crude extracts, their use in
biopharmaceuticals require high levels of purity that make downstream
processing with separation and purification steps critical. Separation
technology is vital since it plays a major role in influencing product efficacy
and ability to achieve regulatory conformance.
Separation
processes in the area of biotechnology make use of a wide range of advanced
separating systems including liquid chromatography, microarrays,
electrophoresis, membrane filtration, flow cytometry and centrifugation
technologies, among others. These biotechnology separation systems are used for
a wide range of purposes, including production of enzymes, vaccines, insulin
and hormones for therapeutic applications in the pharmaceutical industry, along
with other uses in applications such as energy and food production. Increasing
demand for biotechnology products and technological advances in separation
technologies are driving growth in the market. The emergence of the pharmaceutical
sector as a high impact end-use sector is fundamentally changing the way these separation
devices are built, given the high safety and hygienic requirements in the
pharma industry. Liquid chromatography represents the most commonly adopted
separation methodology in the area of bioprocessing. From a research-dedicated
tool in life sciences, liquid chromatography has evolved to become a key
technology in commercial applications of biotechnology.
As stated by the
new market research report on Commercial
Biotechnology Separation Systems, the United States represents the largest
market worldwide. Strong government support of the biosimilars market and effervescent
drug pipeline in the biopharmaceutical industry, represent key factors fuelling
the country’s dominance. Asia-Pacific ranks as the fastest growing market with
a CAGR of 6.2% over the analysis period, led by robust lifesciences and
biotechnology research activity, increased understanding of contemporary biotechnology
principles and practices, and growing domestic production of drugs, food
products and cosmetics.
Key
players in the market include 3M , AB Sciex, Agilent Technologies Inc., Alfa
Laval AB, Alfa Wassermann Separation Technologies LLC, Beckman Coulter Inc.,
Becton Dickinson and Company, Bio-Rad Laboratories Inc., Flottweg SE, Fluidigm
Corporation, GE Healthcare, Groupe Novasep, Hitachi High-Technologies Corp.,
Illumina Inc., Merck KGaA, Pall Corporation, PerkinElmer Inc., ProMetic Life
Sciences Inc., Repligen Corporation, Sartorius Stedim Biotech SA, SEPMAG,
Shimadzu Scientific Instruments, Sysmex Partec GmbH, and Thermo Fisher
Scientific Inc., among others.
The
research report titled “Commercial
Biotechnology Separation Systems - Market Analysis, Trends, and Forecasts”
announced by Global Industry Analysts Inc.,
provides a comprehensive review of market trends, drivers, mergers,
acquisitions and other strategic industry activities of major companies. The
report provides market estimates and projections for all major geographic
markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK,
Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, and Rest of
Asia-Pacific), Middle East & Africa, and Latin America (Brazil, and Rest of
Latin America). The types of separation system analyzed for the global market in
the report include DNA Microarray, Flow Cytometry, Liquid Chromatography,
Membrane Filtration, Protein Microarray, and Others.
For
enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.
For cutting edge analyst reviews on top industries
Comments
Post a Comment